AzTrials
AzTrials

Dental Implant Failure NosLaser-LokNCT03982615

Impact of Laser-modified Abutment Topography on Peri-implant Mucosal Integration

A study testing Laser-Lok abutment and Standard healing abutment in people with Dental Implant Failure Nos, run by University of Illinois Chicago at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is a prospective randomized split mouth study intended to evaluate the healing and health of peri-implant mucosal tissue following placement of titanium abutments with or without laser-etching. Each subject will receive two implants. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Dental Implant Failure Nos
What is being tested?
Laser-Lok abutment and Standard healing abutment
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
8 May 2019to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adult, able to provide informed written consent and available for 1 year follow-up visit
  • Have 2 edentulous sites requiring single tooth implants for restoration in two separate quadrants
  • Implant sites must be restorable with 4.2mm diameter implants
  • Have natural teeth adjacent (at least unilaterally) to proposed implant sites
  • Able to pay for implant crowns at UIC College of Dentistry postgraduate fees to complete treatment

Who cannot join

  • Uncontrolled/rampant caries or periodontal disease
  • Unable to demonstrate adequate home oral hygiene
  • smoker within the past 6 months
  • ASA Class 3+, immune-compromised
  • Pregnant or planning to become pregnant within 6 months
  • Severe bruxism
Show all 9Show fewer
  • History of bisphosphonate use
  • Bone grafting required for implant placement
  • Missing tooth is too small to be restored using a 4.2mm implant

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Illinois at Chicago, College of Dentistry, Clinical Research Center

    Chicago, Illinois, 60612

Other trials in United States

About this study

Official title: The Laser-Lok Trial: Impact of Laser-modified Abutment Topography on Peri-implant Mucosal Integration

This study is a prospective randomized split mouth study intended to evaluate the healing and health of peri-implant mucosal tissue following placement of titanium abutments with or without laser-etching.

Each subject will receive two implants. Following placement of the two 4.2mm diameter implants, one implant will receive (by randomization) a laser-etched abutment ('Laser-Lok'). The other implant will receive a standard, non-etched healing abutment. Subjects will be sequentially subdivided into four groups (n=5) and scheduled for a biopsy of the peri-implant tissues of both implants at either 8 weeks, 4 weeks, 2 weeks or 1 week after implant surgery. These biopsies, about the size of a grain of rice, will be analyzed using immunohistochemical and RNASeq techniques to identify molecular changes in response to laser etching.

At approximately 8 weeks after implant surgery, subjects will have abutments removed from both implants and digital impressions taken for final crown fabrication. At approximately 11-12 weeks after implant surgery, final crowns will be placed. Subjects return to clinic at approximately 1 year post surgery for a final study visit to assess the peri-implant mucosa surrounding both implants as measured by bleeding upon probing, probing depth and peri-apical radiography.

Read the detailed description

A dental implant is an artificial "root" for a missing tooth made out of surgical grade metals, usually titanium, which is placed in the jaw. An implant is designed to provide a strong foundation for an artificial replacement tooth, also called a "crown". An abutment is a medical grade connector, usually made of titanium, which is placed on top of the implant, and is designed to hold and connect the crown to the implant. A crown, also called a "dental cap" is an artificial tooth, generally made of porcelain or surgical grade metals.

Osseointegration is defined as the fusion of a dental implant and abutment with the surrounding jaw bone and is a critical step during implant therapy. During this process, the titanium and bone need to become one solid structure (without any intervening inflammatory mucosal tissue in between) for optimum strength and viability.

It is hypothesized that use of an abutment whose surface has been etched with a laser ("laser-etched") will enhance the attachment of the abutment to the surrounding bone and mucosal tissue and optimize healing.

The goal of this research is to compare, by split mouth design, the healing process of peri-implant mucosal tissue adjacent to a standard healing abutment (not laser-etched) versus mucosal tissue healing adjacent to a laser-etched abutment .

Each subject will receive two implants. One implant will receive (by randomization) a standard titanium healing abutment that is not laser-etched. The other implant will receive a laser-etched ("Laser-Lok") abutment. Subjects will be sequentially subdivided into 4 groups (n=5) and scheduled for a biopsy of peri-implant tissue at both implant sites at either 8 weeks, 4 weeks, 2 weeks or 1 week after implant surgery. The biopsies, about the size of a grain of rice, will be analyzed using histological and molecular techniques to identify cellular changes in response to laser-etching.

Approximately 8 weeks after implant placement, subject will have abutments removed and digital impressions taken for final crown fabrication. At approximately 11-12 weeks post implant placement, final crowns will be placed. Subjects return to clinic at approximately 1 year post surgery for a final study visit to assess the peri-implant mucosa around both implants as measured by bleeding upon probing, probing depth and peri-apical radiography.

Being tested
Laser-Lok abutment, Standard healing abutment
Keywords
RNASeq, mucosal integration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laser-Lok abutmentDevice

    Also called laser-etched abutment

    Each subject will receive two dental implants. One implant will receive (by randomization) a laser-etched ("Laser-Lok") abutment.

  • Standard healing abutmentDevice

    Also called non-laser etched abutment

    Each subject will receive two dental implants. One implant will receive (by randomization) receive a standard healing abutment (not laser-etched).

Study groups in NCT03982615
Study groupRoleWhat they receive
Laser-Lok abutmentExperimentalLaser-etched abutment
Receives: Device: Laser-Lok abutment
Standard Healing abutmentActive comparatorStandard abutment which is not laser-etched
Receives: Device: Standard healing abutment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Molecular profiling of peri-implant mucosal tissues

    Fold change (> 2 fold) expression of junctional epithelial gene expression (e.g. ODAM., FDSCP)

    Measured: 1 week, 2 week, 4 week, and 8 week after implant surgery

Secondary outcomes (1)
  1. Radiographic parameter

    mm change (> 0.1 mm) in peri-implant bone levels at mesial and distal positions

    Measured: 1 week and 1 year post implant surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2019
  2. Study start8 May 2019
  3. Primary completion30 Jul 2021 (estimated)
  4. Study completion31 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospective randomized split mouth designed study intended to evaluate the healing and health of peri-implant mucosa following placement of titanium abutments with or without laser-etching. Each subject will receive two dental implants. One implant will receive (by randomization) a laser-etched ("Laser-Lok") abutment. The other implant will receive a standard healing abutment (not laser-etched).
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03982615
Sponsor's protocol ID
2018-1358
Acronym
Laser-Lok
Status last verified
Mar 2021
First submitted
21 May 2019
Last updated
26 Mar 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Leong A, De Kok I, Mendonca D, Cooper LF. Molecular Assessment of Human Peri-implant Mucosal Healing at Laser-Modified and Machined Titanium Abutments. Int J Oral Maxillofac Implants. 2018 Jul/Aug;33(4):895-904. doi: 10.11607/jomi.6367.

    PubMed 30025007

Questions about this trial

What is this clinical trial studying?

A study testing Laser-Lok abutment and Standard healing abutment in people with Dental Implant Failure Nos, run by University of Illinois Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Molecular profiling of peri-implant mucosal tissues (time frame: 1 week, 2 week, 4 week, and 8 week after implant surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03982615, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in